Hepion Pharmaceuticals Inc (HEPA)
2.13
+0.09
(+4.41%)
USD |
NASDAQ |
Apr 17, 16:00
2.00
-0.13
(-6.10%)
After-Hours: 20:00
Hepion Pharmaceuticals Price: 2.13 for April 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 17, 2024 | 2.051 | 2.21 | 2.00 | 2.13 | 21477.00 |
Apr 16, 2024 | 2.14 | 2.24 | 2.04 | 2.04 | 25633.00 |
Apr 15, 2024 | 2.24 | 2.35 | 2.16 | 2.18 | 10027.00 |
Apr 12, 2024 | 2.22 | 2.30 | 2.18 | 2.19 | 16941.00 |
Apr 11, 2024 | 2.354 | 2.354 | 2.08 | 2.23 | 34462.00 |
Apr 10, 2024 | 2.46 | 2.46 | 2.22 | 2.28 | 35155.00 |
Apr 09, 2024 | 2.52 | 2.56 | 2.38 | 2.44 | 17724.00 |
Apr 08, 2024 | 2.49 | 2.61 | 2.47 | 2.56 | 16226.00 |
Apr 05, 2024 | 2.61 | 2.640 | 2.485 | 2.52 | 29976.00 |
Apr 04, 2024 | 2.55 | 2.900 | 2.41 | 2.64 | 122312.0 |
Apr 03, 2024 | 2.245 | 2.56 | 2.245 | 2.56 | 45522.00 |
Apr 02, 2024 | 2.39 | 2.39 | 2.22 | 2.29 | 26580.00 |
Apr 01, 2024 | 2.44 | 2.45 | 2.31 | 2.36 | 39583.00 |
Mar 28, 2024 | 2.47 | 2.528 | 2.42 | 2.49 | 21291.00 |
Mar 27, 2024 | 2.30 | 2.56 | 2.220 | 2.50 | 51687.00 |
Mar 26, 2024 | 2.25 | 2.41 | 2.25 | 2.32 | 32817.00 |
Mar 25, 2024 | 2.28 | 2.369 | 2.21 | 2.25 | 8445.00 |
Mar 22, 2024 | 2.32 | 2.415 | 2.05 | 2.35 | 25902.00 |
Mar 21, 2024 | 2.212 | 2.34 | 2.20 | 2.32 | 14562.00 |
Mar 20, 2024 | 2.11 | 2.35 | 2.05 | 2.34 | 12473.00 |
Mar 19, 2024 | 2.20 | 2.29 | 2.07 | 2.13 | 24851.00 |
Mar 18, 2024 | 2.07 | 2.21 | 2.07 | 2.18 | 45789.00 |
Mar 15, 2024 | 2.20 | 2.36 | 1.96 | 2.26 | 40819.00 |
Mar 14, 2024 | 2.07 | 2.314 | 1.89 | 2.04 | 50387.00 |
Mar 13, 2024 | 2.12 | 2.44 | 2.02 | 2.09 | 74556.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.511
Minimum
Feb 08 2024
319.20
Maximum
Apr 18 2019
37.59
Average
29.20
Median
Aug 03 2021
Price Benchmarks
Ionis Pharmaceuticals Inc | 40.91 |
Madrigal Pharmaceuticals Inc | 228.34 |
Galectin Therapeutics Inc | 3.38 |
Viking Therapeutics Inc | 66.54 |
89bio Inc | 9.185 |
Price Related Metrics
Price to Book Value | 2.087 |
Earnings Yield | -578.4% |
Market Cap | 8.675M |